Find out about the innovations in dementia treatment, particularly new therapies that target Alzheimer's disease and improve quality of life.

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study. Although DLB is the second most common neurodegenerative dementia following Alzheimer's ...

NewDays, an AI company delivering cognitive health treatment, has raised $7 million in seed funding from General Catalyst and Madrona, the startup announced on Wednesday. It’s estimated that about one ...

There is currently no cure for dementia, which afflicts an estimated 57 million people globally, and affects hundreds of millions more who are the family, friends, and caretakers of people with ...

Glucose-lowering therapies did not exhibit an overall decreased risk for dementia, cognitive impairment, or dementia subtypes. Use of cardioprotective glucose-lowering therapies does not affect ...